Literature DB >> 3279073

Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases.

J Slots1, M A Listgarten.   

Abstract

Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans seem to be major pathogens in advancing periodontitis in man. First, these organisms are recovered in higher prevalence and proportions from progressive periodontitis lesions than from quiescent periodontal sites. Second, antibody levels against B. gingivalis and A. actinomycetemcomitans are markedly elevated in serum and gingival crevice fluid of periodontitis patients compared to normal controls. Third, B. gingivalis and B. intermedius elaborate potent proteases and A. actinomycetemcomitans various noxious substances which have the potential to perturb important host defenses and to disintegrate key constituents of the periodontal tissues. Monitoring these bacteria in advanced periodontal lesions may greatly assist the assessment of treatment efficacy and risk of further periodontal breakdown.

Entities:  

Mesh:

Year:  1988        PMID: 3279073     DOI: 10.1111/j.1600-051x.1988.tb00999.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  103 in total

1.  Identification of genes coding for exported proteins of Actinobacillus actinomycetemcomitans.

Authors:  K P Mintz; P M Fives-Taylor
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  impA, a gene coding for an inner membrane protein, influences colonial morphology of Actinobacillus actinomycetemcomitans.

Authors:  K P Mintz; P M Fives-Taylor
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Anti-inflammatory effect of heme oxygenase-1 toward Porphyromonas gingivalis lipopolysaccharide in macrophages exposed to gomisins A, G, and J.

Authors:  Eun Yeon Ryu; Sun Young Park; Sun Gun Kim; Da Jung Park; Jum Soon Kang; Young Hun Kim; Rajaseker Seetharaman; Young-Whan Choi; Sang-Joon Lee
Journal:  J Med Food       Date:  2011-12       Impact factor: 2.786

4.  The hemoglobin receptor protein of porphyromonas gingivalis inhibits receptor activator NF-kappaB ligand-induced osteoclastogenesis from bone marrow macrophages.

Authors:  Yuji Fujimura; Hitoshi Hotokezaka; Naoya Ohara; Mariko Naito; Eiko Sakai; Mamiko Yoshimura; Yuka Narita; Hideki Kitaura; Noriaki Yoshida; Koji Nakayama
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

5.  Feasibility of an HA2 domain-based periodontitis vaccine.

Authors:  A A DeCarlo; Y Huang; C A Collyer; D B Langley; J Katz
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

6.  Stability study of tetracyclines with respect to their use in slow release systems.

Authors:  V C Honnorat-Benabbou; A A Lebugle; B Sallek; D Duffaut-Lagarrigue
Journal:  J Mater Sci Mater Med       Date:  2001-02       Impact factor: 3.896

7.  Isolation, cloning, and expression of an acid phosphatase containing phosphotyrosyl phosphatase activity from Prevotella intermedia.

Authors:  X Chen; T Ansai; S Awano; T Iida; S Barik; T Takehara
Journal:  J Bacteriol       Date:  1999-11       Impact factor: 3.490

8.  Immunobiological activities of a 55-kilodalton cell surface protein of Prevotella intermedia ATCC 25611.

Authors:  K Matsushita; S Nagaoka; R Arakaki; Y Kawabata; K Iki; M Kawagoe; H Takada
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  Inflammatory cytokine gene expression in human periodontal ligament fibroblasts stimulated with bacterial lipopolysaccharides.

Authors:  Y Yamaji; T Kubota; K Sasaguri; S Sato; Y Suzuki; H Kumada; T Umemoto
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  Initial serum antibody titer to Porphyromonas gingivalis influences development of antibody avidity and success of therapy for chronic periodontitis.

Authors:  J Mooney; E Adonogianaki; M P Riggio; K Takahashi; A Haerian; D F Kinane
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.